BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Valeant Pharmaceuticals International 

Worldwide Headquarters
One Enterprise
Aliso Viejo  California  92656  U.S.A.
Phone: 800-548-5100 or 949-461-6000 Fax: 714-556-0131


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical


Collaborations

Metabasis Therapeutics, Inc.  – Hepatitis B





 Company News
Valeant Pharmaceuticals International (VRX) Announces 2013 Annual Meeting Results 5/22/2013 6:10:57 AM    More...
Valeant Pharmaceuticals International (VRX) to Present at 34th Annual Goldman, Sachs & Co. Global Healthcare Conference 5/21/2013 6:32:42 AM    More...
Valeant Pharmaceuticals International (VRX) Announces Resignation of Dr. Laurence Paul from Valeant's Board of Directors 5/16/2013 7:12:39 AM    More...
Valeant Pharmaceuticals International (VRX) to Webcast 2013 Annual Meeting of Shareholders 5/14/2013 6:55:06 AM    More...
Valeant Pharmaceuticals International (VRX) Announces Additional Information Regarding Continuance Proposal 5/13/2013 9:51:52 AM    More...
Valeant Pharmaceuticals International (VRX) Provides Efinconazole Update 5/3/2013 9:35:13 AM    More...
Valeant Pharmaceuticals International (VRX) Reports 2013 First Quarter Financial Results 5/2/2013 7:01:58 AM    More...
Actavis Buys Antibiotic Vaginal Gel From Valeant Pharmaceuticals International (VRX) for $55 Million 5/1/2013 7:30:00 AM    More...
Valeant Pharmaceuticals International (VRX) in Talks to Buy Actavis for Over $13 Billion Put on Hold 4/29/2013 8:13:30 AM    More...
Valeant Pharmaceuticals International (VRX) Completes Tender Offer for Obagi Medical Products, Inc. (OMPI) 4/25/2013 11:21:05 AM    More...
12345678910...